-+ 0.00%
-+ 0.00%
-+ 0.00%

DA Davidson Maintains Neutral on Medifast, Lowers Price Target to $16.5

Benzinga·02/19/2025 21:01:23
Listen to the news
DA Davidson analyst Linda Bolton Weiser maintains Medifast (NYSE:MED) with a Neutral and lowers the price target from $17 to $16.5.